Aqua Bio Technology ASA (OSL:ABTEC)

Market Cap	91.53M
Revenue (ttm)	13.82M
Net Income (ttm)	-1.50M
Shares Out	157.27M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220,581
Average Volume	371,908
Open	0.5900
Previous Close	0.5900
Day's Range	0.5820 - 0.6080
52-Week Range	1.6050 - 6.4000
Beta	0.78
RSI	29.17
Earnings Date	Apr 29, 2025

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 4
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2022, Aqua Bio Technology ASA's revenue was 7.16 million, an increase of 262.49% compared to the previous year's 1.98 million. Losses were -18.74 million, -1.97% less than in 2021.